Semaglutide for Weight Loss: Effectiveness, Dosage, Side Effects, Safety and Cost

Semaglutide is a prescription GLP-1 receptor agonist that may support weight loss by influencing appetite regulation, increasing feelings of fullness, slowing gastric emptying, and reducing calorie intake. Treatment can involve injectable or oral formulations, with dosing schedules that typically start low and increase gradually. As of September 2026, Wegovy is commonly  available in the U.S. as both an injection and oral tablet for weight reduction in eligible adults, while Wegovy injection is also approved for eligible adolescents aged 12 and older. Ozempic can contain the same active ingredient but has different approved indications. Missed-dose instructions differ between injections and pills, so patients should follow guidance for their prescribed formulation.

In clinical studies, semaglutide has supported meaningful weight reduction, with changes sometimes appearing within the first few weeks and becoming more substantial over several months. Eligibility can include adults with obesity, adults with overweight and a qualifying weight-related condition, and certain adolescents who meet specific criteria. Diabetes is not required for weight-management eligibility. However, semaglutide is not appropriate for everyone. Medical assessment is particularly important for people with medullary thyroid carcinoma risk, MEN 2, pregnancy, breastfeeding considerations, or a history of pancreatitis.

What Is Semaglutide?

Semaglutide is a prescription medicine and GLP-1 receptor agonist that can help manage blood sugar in type 2 diabetes and support long-term weight management in eligible people with obesity or overweight. It works like the natural GLP-1 hormone and may help the body release insulin when blood sugar is high, reduce glucagon secretion, slow gastric emptying, and increase feelings of fullness. In the US, semaglutide is commonly available in injectable and oral forms under brands including Ozempic, Wegovy, and Rybelsus. Approved indications vary by product and patient population and can include type 2 diabetes, chronic weight management, and certain cardiovascular, kidney, and MASH-related indications.

How Does Semaglutide Work for Weight Loss?

Semaglutide may support weight loss by acting on GLP-1 receptors involved in appetite regulation, which can reduce appetite, increase feelings of fullness, slow gastric emptying, and contribute to lower calorie intake. These combined effects can make it easier for some people to eat smaller portions and consume fewer calories over time as part of a medically supervised weight-management plan.

5  ways semaglutide supports weight loss are:

1. Reduces appetite

Semaglutide may reduce appetite by decreasing hunger, desire to eat, food cravings, and prospective food consumption. For some people, these changes can also reduce food cravings and make smaller portions feel more satisfying, lowering overall calorie intake. In a randomized trial of adults with obesity, semaglutide 2.4 mg reduced ad libitum energy intake by 35% compared with placebo and was associated with significantly less hunger, greater fullness and satiety, and fewer food cravings (Friedrichsen et al., 2021). These appetite-related effects can contribute to gradual weight management when semaglutide is used as prescribed alongside appropriate diet and lifestyle changes.

2. Increases fullness and satiety

When semaglutide acts on GLP-1 receptors in areas of the brain involved in appetite and satiety, it can strengthen the signals that tell the body enough food has been consumed. These appetite signals may help some people feel satisfied after eating smaller amounts and maintain that sense of fullness after a meal. As a result, the desire to continue eating or have additional food may decrease. Over time, smaller meal portions and reduced food intake can contribute to lower calorie intake and support weight management when semaglutide is used as prescribed.

3. Slows gastric emptying

Semaglutide may delay gastric emptying, meaning food can move from the stomach into the small intestine more slowly after eating. The magnitude and persistence of this effect may vary by dose and treatment stage. In Hjerpsted et al. (2018), semaglutide 1.0 mg was associated with 27% lower gastric emptying during the first hour, but no significant difference was found across the full five-hour post-meal period. A later study of semaglutide 2.4 mg found no evidence of delayed gastric emptying at week 20 using an indirect assessment (Friedrichsen et al., 2021). These findings suggest that effects on gastric emptying may not remain consistent throughout treatment.

4. Reduces calorie intake

When semaglutide reduces hunger and increases feelings of fullness, some people may naturally consume fewer calories throughout the day. Feeling satisfied after eating less food can lead to smaller portions, while reduced hunger and food cravings may decrease food consumption at meals and between meals. In a 60-week randomized trial, participants taking semaglutide 2.4 mg consumed about 292 fewer calories during an ad libitum laboratory lunch at week 20, 240 fewer calories at week 40, and 270 fewer calories at week 60 compared with placebo (Tronieri et al., 2026). These figures represent differences in intake during the test meal, not reductions in total daily calorie intake. 

5. Acts on GLP-1 receptors involved in appetite regulation

Semaglutide can activate GLP-1 receptors involved in regulating appetite and calorie intake. GLP-1 is a natural physiological regulator of appetite, and its receptors are present in several areas of the brain associated with appetite regulation.GLP-1 is a natural regulator of appetite and calorie intake, and its receptors are found in several brain regions that help control eating behavior. By activating the GLP-1 receptor, semaglutide can affect appetite-related signaling that controls hunger, fullness, and food intake. Over time, lower energy intake can contribute to weight loss when semaglutide is prescribed as part of a weight-management plan.

What Is the Semaglutide Dosage for Weight Loss?

Semaglutide dosage for weight loss may range from a low starting dose to a higher maintenance dose, depending on the formulation and treatment stage. Injectable semaglutide may start at 0.25 mg once weekly and gradually increase to 2.4 mg, while oral semaglutide may start at 1.5 mg once daily and increase to 25 mg. The prescribed schedule can depend on treatment response and tolerability.

Semaglutide Injection Dosage Schedule

In clinical studies of injectable semaglutide for weight management, participants typically started with 0.25 mg once weekly for four weeks, followed by dose increases every four weeks to 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg once weekly by week 16. The NCBI clinical review specifically reports this 16-week dose-escalation schedule across the STEP trials, with each lower dose used for approximately four weeks before participants reached the studied 2.4 mg maintenance dose.

Semaglutide injection is generally prescribed for once-weekly use, often on the same day each week. The maintenance dose and timing of dose increases may vary based on the specific semaglutide product, treatment purpose, tolerability, and individual response. A healthcare professional can determine the appropriate dosing schedule, and patients should follow their prescribed instructions before making any changes to their dose.

Semaglutide Pill Dosage Schedule

Oral semaglutide is generally taken once daily, starting with a lower tablet strength before increasing to an escalation or maintenance dose according to the prescribed formulation. Current FDA-approved oral formulations use different tablet strengths and are not interchangeable milligram for milligram. FDA-approved oral semaglutide dosing should not be presented as a general weight-loss tablet schedule because the approved indication depends on the specific oral product and current prescribing information.

Take oral semaglutide in the morning on an empty stomach with up to 4 ounces (120 mL) of plain water. Swallow the tablet whole, then wait at least 30 minutes before eating, drinking other beverages or taking other oral medicines. The exact tablet strength and dose-escalation schedule depend on the prescribed formulation and treatment indication, so patients should follow their healthcare professional’s instructions.

What Happens If You Miss a Dose of Semaglutide?

If you miss a dose of semaglutide, you may need to take the missed dose, skip it, or resume your regular schedule depending on whether you use a weekly injection or daily pill and the specific product instructions. Missed-dose guidance differs between semaglutide formulations, so one dosing rule does not apply to everyone. For semaglutide injections, the next step depends on how much time has passed and when your next weekly dose is due. For semaglutide pills, separate missed-dose instructions apply to daily use. Follow the current instructions for your prescribed formulation rather than doubling or changing the dose yourself.

Injection

If you miss a weekly semaglutide injection, whether you should take or skip the missed dose depends on the specific formulation, the time since the missed injection, and how close you are to your next scheduled dose. Current FDA prescribing information differs between injectable formulations. One provides a 5-day window for taking a missed dose, while another advises taking it only when the next scheduled dose is more than 48 hours away. Once the applicable window has passed, the missed dose should generally be skipped, and the regular weekly schedule resumed rather than taking doses too close together. If you miss multiple consecutive doses, consult your healthcare professional before restarting, as your dosing schedule may need to be reassessed or gradually increased again.

Pill

For a missed daily semaglutide tablet, current FDA prescribing information advises skipping that dose and taking the next scheduled dose the following day. Do not take 2 tablets or an extra dose to replace the missed one, even if you remember later in the day. Oral semaglutide follows a once-daily dosing schedule with specific administration requirements, so the missed tablet should not be added to a later dose. Resume your prescribed dose the next day and continue following the required fasting, water, and meal-timing instructions to support proper absorption. When several daily doses have been missed, or treatment has been interrupted for an extended period, contact your healthcare professional for guidance before changing your dose or schedule.

How Effective Is Semaglutide for Weight Loss?

Semaglutide can be effective for weight loss, with many people achieving meaningful reductions in body weight over several months of continued treatment. Its effects on appetite, fullness, and calorie intake can support gradual weight reduction. However, the level of effectiveness varies between individuals based on dose, treatment duration, adherence, lifestyle changes, and individual response.

How Much Weight Can You Lose With Semaglutide?

People taking semaglutide for weight management may lose around 10% to 15% of their starting body weight on average, although results vary by dose, treatment duration, adherence, and individual response. In the STEP 1 trial of 1,961 adults with overweight or obesity without diabetes, participants receiving semaglutide 2.4 mg lost an average of 14.9% of their body weight over 68 weeks, compared with 2.4% with placebo. About 69.1% lost at least 10% of their starting weight, and 50.5% lost 15% or more (Wilding et al., 2021). More recent trials reported 13.6% average weight loss with 25 mg oral semaglutide at 64 weeks (Wharton et al., 2025a) and 18.7% with 7.2 mg weekly semaglutide at 72 weeks (Wharton et al., 2025b). These findings show that semaglutide can produce substantial weight loss, but the amount can vary considerably between individuals.

How Long Does Semaglutide Take to Work for Weight Loss?

Semaglutide can begin producing measurable weight loss within the first few weeks of treatment, although the timing and amount of weight loss vary between individuals. In the STEP 1 trial, weight reductions were observed by the first assessment at week 4, with participants receiving semaglutide 2.4 mg losing an average of 14.9% by week 68 (Wilding et al., 2021). In the STEP 4 trial, participants lost an average of 10.6% by week 20, with those continuing treatment losing an additional 7.9% after week 20 (Rubino et al., 2021). This evidence suggests that some people may notice early weight changes within about a month, while greater weight loss typically develops over several months of continued treatment.

Who can Take Semaglutide for Weight Loss?

Semaglutide for weight loss may be prescribed to adults with obesity, adults with a BMI of 27 or higher who have at least one weight-related condition, and eligible adolescents aged 12 years or older who meet specific weight criteria. A healthcare professional can assess whether semaglutide is appropriate based on a person’s weight, medical history, treatment needs, and potential health risks.

Below are 3  groups who may be eligible for semaglutide:

1. Adults with obesity

Adults with obesity, defined as a BMI of 30 kg/m² or higher, may be eligible for semaglutide because obesity is associated with increased risk of conditions such as high blood pressure, type 2 diabetes, and abnormal cholesterol levels. Managing excess body weight may therefore play an important role in reducing these weight-related health risks over time. Semaglutide may support long-term weight management by reducing appetite and energy intake when used alongside diet and physical activity.

2. Adults with a BMI of 27+ plus a weight-related condition

Semaglutide may be suitable for individuals with a BMI of 27 kg/m² or higher and at least one weight-related condition, such as hypertension or dyslipidemia. For these individuals, weight management may be particularly important because excess body weight can add to the health burden associated with an existing weight-related condition. Semaglutide may support weight management by reducing appetite and calorie intake when used alongside diet and physical activity.

3. Adolescents 12+ meeting weight criteria (Wegovy)

For adolescents aged 12 years or older who meet the clinical criteria for obesity, semaglutide may provide an additional treatment option when diet and physical activity alone have not produced sufficient weight-management results. Semaglutide can influence appetite and energy intake, which may help eligible adolescents manage excess body weight over time. Eligibility is determined using age- and sex-specific BMI criteria, along with individual health and treatment needs.

Do You Need Diabetes to Take Semaglutide for Weight Loss?

No, adults do not need to have diabetes to take semaglutide for weight management because eligibility can be based on body weight and weight-related health risks rather than diabetes status. Adults with obesity, or those with overweight and at least one weight-related condition, may qualify depending on the approved indication. In the SELECT trial of 17,604 adults with overweight or obesity without diabetes, participants receiving semaglutide had an average 10.2% reduction in body weight at  4  years, compared with 1.5% with placebo (Ryan et al., 2024). Individual eligibility still depends on medical history, treatment needs, and assessment by a healthcare professional.

Who Should Not Take Semaglutide?

People who may need to avoid semaglutide or receive additional medical assessment before treatment include those with a personal or family history of medullary thyroid carcinoma, MEN 2, pregnancy or breastfeeding, or a history of pancreatitis. These factors can affect the safety or suitability of treatment, so a healthcare professional should review a person’s medical history and current health status before semaglutide is prescribed.

Below are 4  groups who may need to avoid semaglutide :

1. Personal/family history of medullary thyroid cancer

People with a personal or family history of medullary thyroid carcinoma (MTC) should not use FDA-approved semaglutide products that list this condition as a contraindication. Semaglutide caused thyroid C-cell tumors in animal studies, although it remains unknown whether it causes these tumors, including MTC, in humans. Because of this potential risk, current prescribing information contraindicates treatment in people who have had MTC or have a family history of the condition.

2. Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Individuals with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not take semaglutide because this inherited condition increases the risk of medullary thyroid carcinoma. Due to this increased thyroid cancer risk, MEN 2 is listed as a contraindication in semaglutide prescribing information.

3. Pregnant or breastfeeding Women

Pregnant women should not use semaglutide for weight loss because it may cause fetal harm, while intentional weight loss during pregnancy may also pose risks to fetal development. Treatment should be stopped when pregnancy is recognized. Breastfeeding requires separate consideration because recommendations vary by semaglutide formulation and potential infant exposure.

4. History of pancreatitis

Individuals with a history of pancreatitis may require additional medical assessment before taking semaglutide, as treatment has been associated with acute pancreatitis, which can cause severe and persistent abdominal pain and may require hospital treatment. A previous episode is not generally listed as a contraindication, but a healthcare professional should assess whether semaglutide is appropriate.

What Are the Side Effects of Semaglutide During Weight Loss?

Common side effects of semaglutide during weight loss are mainly gastrointestinal and may include nausea, vomiting, diarrhea, constipation, and abdominal pain, particularly as the body adjusts to treatment. These adverse reactions are often more noticeable when treatment begins or the dose increases and may lessen as the body adjusts to semaglutide. 

5 common side effects of semaglutide during weight loss are:

• Nausea: Semaglutide may cause an unsettled stomach or the feeling of needing to vomit. Nausea may be more noticeable when treatment starts or the dose increases.
• Vomiting: When the digestive system responds to semaglutide, particularly during treatment initiation or dose increases, vomiting may occur as a gastrointestinal effect. Frequent vomiting can contribute to dehydration and fluid loss.
• Diarrhea: Semaglutide may cause loose or more frequent bowel movements. Persistent diarrhea can increase the risk of dehydration.
• Constipation: Some people may experience less frequent bowel movements or harder stools while taking semaglutide. Symptoms can vary in frequency and severity.
• Abdominal Pain: Semaglutide can cause stomach pain, cramping, or abdominal discomfort. Persistent or severe abdominal pain should be discussed with a healthcare professional.

How Long Do Semaglutide Side Effects Last?

Semaglutide side effects can last from several days to several weeks, depending on the symptom, treatment stage, dose increases, and individual response. Gastrointestinal effects such as nausea and diarrhea are often temporary and may lessen as the body adjusts to treatment, with STEP 1 reporting that these effects typically subsided over time. Symptoms may become more noticeable during dose escalation. Severe or persistent gastrointestinal symptoms, particularly ongoing vomiting, diarrhea, or abdominal pain, should be reviewed by a healthcare professional.

How Does Semaglutide Compare to Other Weight-Loss Medications?

Semaglutide can support weight management by acting on GLP-1 receptors involved in appetite regulation, whereas other weight-loss medications may target different hormone pathways, appetite signals, or dietary fat absorption. These differences can affect how each medication influences hunger and calorie intake, how often it is taken, the amount of weight loss observed in clinical studies, and how healthcare professionals assess its suitability for individual patients.

Is Semaglutide Safe for Weight Loss?

Yes, semaglutide can be safe for weight loss when it is prescribed for an eligible person and used under healthcare professional supervision. However, safety depends on factors such as medical history, contraindications, other medications, appropriate dose escalation, and ongoing monitoring. Serious considerations such as thyroid cancer risk, pancreatitis, gallbladder problems, and kidney complications should be assessed before and during treatment.

How Much Does Semaglutide Cost?

Semaglutide costs start at $220 in Costa Rica, with final pricing depending on the product, dosage, provider, and purchase requirements. For buyers seeking research-grade Semaglutide, costs can also vary based on quantity and supplier pricing. Out-of-pocket expenses may depend on insurance coverage, applicable copays, and available savings programs. Reviewing current prices, product specifications, and coverage options can help clarify the expected total cost before purchasing.